Literature DB >> 24518113

PHIPing out: a genetic basis for tumor ulceration.

Jack L Arbiser1.   

Abstract

Ulceration is a common negative prognostic marker of solid tumors including melanoma. The signaling basis of ulceration is being elucidated. PHIP has been found to be amplified in wild-type melanomas, resulting in Akt activation and aerobic glycolysis (Warburg effect), associated with ulceration. The ulceration phenotype likely represents the genotype of the reactive oxygen driven tumor, in which reactive oxygen drives angiopoietin-2 production, tumor growth, and invasion. This phenotype is amenable to pharmacologic intervention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24518113      PMCID: PMC4412359          DOI: 10.1038/jid.2013.443

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Weight loss-induced calciphylaxis: potential role of matrix metalloproteinases.

Authors:  Girish Munavalli; Amy Reisenauer; Marsha Moses; Susan Kilroy; Jack L Arbiser
Journal:  J Dermatol       Date:  2003-12       Impact factor: 4.005

2.  Efficacy of topical application of eosin for ulcerated hemangiomas.

Authors:  Moshe Lapidoth; Dan Ben-Amitai; Sulochana Bhandarkar; Levi Fried; Jack L Arbiser
Journal:  J Am Acad Dermatol       Date:  2009-02       Impact factor: 11.527

3.  Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.

Authors:  Jennifer M Munson; Levi Fried; Sydney A Rowson; Michael Y Bonner; Lohitash Karumbaiah; Begoña Diaz; Sara A Courtneidge; Ulla G Knaus; Daniel J Brat; Jack L Arbiser; Ravi V Bellamkonda
Journal:  Sci Transl Med       Date:  2012-03-28       Impact factor: 17.956

4.  Overexpression of Akt converts radial growth melanoma to vertical growth melanoma.

Authors:  Baskaran Govindarajan; James E Sligh; Bethaney J Vincent; Meiling Li; Jeffrey A Canter; Brian J Nickoloff; Richard J Rodenburg; Jan A Smeitink; Larry Oberley; Yuping Zhang; Joyce Slingerland; Rebecca S Arnold; J David Lambeth; Cynthia Cohen; Lu Hilenski; Kathy Griendling; Marta Martínez-Diez; José M Cuezva; Jack L Arbiser
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

Review 5.  The reactive oxygen-driven tumor: relevance to melanoma.

Authors:  Levi Fried; Jack L Arbiser
Journal:  Pigment Cell Melanoma Res       Date:  2008-04-01       Impact factor: 4.693

6.  High-level expression of vascular endothelial growth factor and its receptors in an aphthous ulcer.

Authors:  Jack L Arbiser; Darlene Johnson; Cynthia Cohen; Lawrence F Brown
Journal:  J Cutan Med Surg       Date:  2003 May-Jun       Impact factor: 2.092

7.  Angiopoietin-2 is increased in septic shock: evidence for the existence of a circulating factor stimulating its release from human monocytes.

Authors:  Hariklia Kranidioti; Stylianos E Orfanos; Ilia Vaki; Anastasia Kotanidou; Maria Raftogiannis; Ioanna Dimopoulou; Antigoni Kotsaki; Athina Savva; Andreas Papapetropoulos; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  Immunol Lett       Date:  2009-06-17       Impact factor: 3.685

8.  Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma.

Authors:  Iris Helfrich; Lutz Edler; Antje Sucker; Markus Thomas; Sven Christian; Dirk Schadendorf; Hellmut G Augustin
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

9.  Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma.

Authors:  S Tanaka; M Mori; Y Sakamoto; M Makuuchi; K Sugimachi; J R Wands
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

10.  Prognostic impact of PHIP copy number in melanoma: linkage to ulceration.

Authors:  Vladimir Bezrookove; David De Semir; Mehdi Nosrati; Schuyler Tong; Clayton Wu; Suresh Thummala; Altaf A Dar; Stanley P L Leong; James E Cleaver; Richard W Sagebiel; James R Miller; Mohammed Kashani-Sabet
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

View more
  1 in total

1.  PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.

Authors:  David de Semir; Vladimir Bezrookove; Mehdi Nosrati; Altaf A Dar; Clayton Wu; Julia Shen; Christopher Rieken; Meenakshi Venkatasubramanian; James R Miller; Pierre-Yves Desprez; Sean McAllister; Liliana Soroceanu; Robert J Debs; Nathan Salomonis; Dirk Schadendorf; James E Cleaver; Mohammed Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-04       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.